Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06773000 · ClinicalTrials.gov registry record · NA
Nutritional Supplementation in Geriatric Hip Fractures
A NA study of Geriatric Hip Fracture, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT06773000 is a NA study of Geriatric Hip Fracture that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 118 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06773000, a NA study of Geriatric Hip Fracture, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized controlled trial comparing outcomes between geriatric hip fractures who received a commercially available (XR RecoveryTM, Salt Lake City Utah) peri-operative nutritional supplement for three weeks post-operatively to those who receive standard nutritional counseling. The main question it aims to answer is: \- Does supplementation decrease muscle loss via ultrasound measurements of the cross-sectional area of the rectus femoris of the uninjured leg?
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT XR™ Recovery Supplement
- DIETARY_SUPPLEMENT XR Carbohydrate Loading Supplement
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-01-16 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06773000
The ClinicalTrials.gov registry entry for NCT06773000 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Geriatric Hip Fracture appearing as the primary indexed condition, and to 2 interventions - of which XR™ Recovery Supplement is the first listed.
NCT06773000 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06773000 about?
NCT06773000 is a clinical study titled "Nutritional Supplementation in Geriatric Hip Fractures". This study is a randomized controlled trial comparing outcomes between geriatric hip fractures who received a commercially available (XR RecoveryTM, Salt Lake City Utah) peri-operative nutritional supplement for three weeks post-operatively to those who receive standard nutritional counseling. The m...
What is the current status of trial NCT06773000?
This trial is currently recruiting. It is a NA study. The enrollment target is 118 participants. The study started on 2025-01-16. Estimated completion is 2027-06-30.
What conditions does trial NCT06773000 study?
This clinical trial studies the following conditions: Geriatric Hip Fracture.
What interventions are being tested in trial NCT06773000?
The interventions under investigation include: XR™ Recovery Supplement (DIETARY_SUPPLEMENT), XR Carbohydrate Loading Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06773000?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06773000 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.